Literature DB >> 16283132

[Diagnosis and treatment of insect venom allergy. An important allergic issue for the ear, nose and throat specialist].

O Pfaar1, L Klimek, I Hansen, B A Stuck, K Hörmann.   

Abstract

The increasing incidence and the potentially life-threatening reactions to venom stings indicate the necessity for otolaryngologists to have a basic knowledge of the diagnosis and treatment of venom allergy. The diagnosis of insect venom allergy is based on the history, skin prick testing (ideally performed as a titration series), and in vitro analysis of specific IgE antibodies to venoms. An emergency medication kit should be prescribed for the patient in case of future venom stings, comprising an H1-blocking antihistamine, a steroid and an adrenaline pen for self-injection. Subcutaneous allergen-specific immunotherapy (sSIT) is the standard treatment to avoid allergic reactions following venom stings in the future. SIT is indicated following all immediate-type reactions to venom stings; contraindications relate to the general recommendations of allergen-specific immunotherapy. Aqueous as well as alum-adsorbed depot allergen preparations can be used for subcutaneous injections. The important dose-increase phase can be performed using conventional, cluster, rush or ultra-rush schedules. Specific immunotherapy is successful in nearly 90% to 100% of patients after 3-5 years of treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16283132     DOI: 10.1007/s00106-005-1331-1

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  37 in total

1.  Hymenoptera venom-specific IgE antibodies in post-mortem sera from victims of sudden, unexpected death.

Authors:  H J Schwartz; C Sutheimer; M B Gauerke; J W Yunginger
Journal:  Clin Allergy       Date:  1988-09

2.  Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings.

Authors:  P W Ewan; J Deighton; A B Wilson; P J Lachmann
Journal:  Clin Exp Allergy       Date:  1993-08       Impact factor: 5.018

3.  Skin and radioallergosorbent tests in patients with sensitivity to bee and wasp venom.

Authors:  M G Harries; D M Kemeny; L J Youlten; M M Mills; M H Lessof
Journal:  Clin Allergy       Date:  1984-09

4.  Dose dependence of Hymenoptera venom immunotherapy.

Authors:  D B Golden; A Kagey-Sobotka; M D Valentine; L M Lichtenstein
Journal:  J Allergy Clin Immunol       Date:  1981-05       Impact factor: 10.793

5.  Rate and quantity of delivery of venom from honeybee stings.

Authors:  M J Schumacher; M S Tveten; N B Egen
Journal:  J Allergy Clin Immunol       Date:  1994-05       Impact factor: 10.793

6.  Diagnosis and treatment of anaphylactic reactions to Hymenoptera stings in children.

Authors:  B E Chipps; M D Valentine; A Kagey-Sobotka; K C Schuberth; L M Lichtenstein
Journal:  J Pediatr       Date:  1980-08       Impact factor: 4.406

7.  Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity.

Authors:  H H Franken; A E Dubois; H J Minkema; S van der Heide; J G de Monchy
Journal:  J Allergy Clin Immunol       Date:  1994-02       Impact factor: 10.793

8.  Treatment failures with whole-body extract therapy of insect sting allergy.

Authors:  D B Golden; J Langois; M D Valentine; A Kagey-Sobotka; L M Lichtenstein
Journal:  JAMA       Date:  1981-11-27       Impact factor: 56.272

Review 9.  Emergency treatment of allergic reactions to Hymenoptera stings.

Authors:  U Müller; H Mosbech; P Blaauw; S Dreborg; H J Malling; B Przybilla; R Urbanek; E Pastorello; M Blanca; J Bousquet
Journal:  Clin Exp Allergy       Date:  1991-05       Impact factor: 5.018

10.  Discontinuation of bee venom immunotherapy in children and adolescents.

Authors:  R Urbanek; J Forster; W Kuhn; J Ziupa
Journal:  J Pediatr       Date:  1985-09       Impact factor: 4.406

View more
  2 in total

Review 1.  [Specific immunotherapy for allergic rhinitis. Current methods and innovative developments].

Authors:  O Pfaar; L Klimek
Journal:  HNO       Date:  2008-08       Impact factor: 1.284

Review 2.  [Management of anaphylaxis. Part 1: Causes and pathophysiology].

Authors:  A Glowania; U Goebel; L Klimek
Journal:  HNO       Date:  2012-11       Impact factor: 1.284

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.